241 related articles for article (PubMed ID: 33441752)
21. Prevalence of Overactive Bladder Symptoms Among Women With Interstitial Cystitis/Bladder Pain Syndrome.
Dubinskaya A; Tholemeier LN; Erickson T; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT
Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):e115-e119. PubMed ID: 35272344
[TBL] [Abstract][Full Text] [Related]
22. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
23. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
24. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
25. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.
Lai HH; Vetter J; Jain S; Gereau RW; Andriole GL
J Urol; 2014 Dec; 192(6):1679-85. PubMed ID: 24907443
[TBL] [Abstract][Full Text] [Related]
26. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.
Tyagi P; Barclay D; Zamora R; Yoshimura N; Peters K; Vodovotz Y; Chancellor M
Int Urol Nephrol; 2010 Sep; 42(3):629-35. PubMed ID: 19784793
[TBL] [Abstract][Full Text] [Related]
27. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers in overactive bladder.
Bhide AA; Cartwright R; Khullar V; Digesu GA
Int Urogynecol J; 2013 Jul; 24(7):1065-72. PubMed ID: 23314226
[TBL] [Abstract][Full Text] [Related]
29. [Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome].
Wang JW; Liu JC; Meng LF; Zhang W; Liu XD; Zhang YG
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):653-658. PubMed ID: 34393223
[TBL] [Abstract][Full Text] [Related]
30. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
31. Overactive bladder and pain: management strategies.
Patel BN; Evans RJ
Curr Urol Rep; 2010 Nov; 11(6):379-84. PubMed ID: 20821355
[TBL] [Abstract][Full Text] [Related]
32. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
33. Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome.
Mu HY; Wu MP; Wang IT; Wu JC; Chin HY
Medicine (Baltimore); 2023 Feb; 102(6):e32790. PubMed ID: 36820564
[TBL] [Abstract][Full Text] [Related]
34. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score.
Humphrey L; Arbuckle R; Moldwin R; Nordling J; van de Merwe JP; Meunier J; Crook T; Abraham L
Eur Urol; 2012 Feb; 61(2):271-9. PubMed ID: 22050826
[TBL] [Abstract][Full Text] [Related]
35. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
Chung SD; Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
[TBL] [Abstract][Full Text] [Related]
36. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
37. Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2024; 36(2):110-119. PubMed ID: 38645782
[TBL] [Abstract][Full Text] [Related]
38. Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC).
Neuhaus J; Schulte-Baukloh H; Stolzenburg JU; Speroni di Fenizio P; Horn LC; Rüffert H; Hartenstein S; Burger M; Schulze M; Schwalenberg T
World J Urol; 2012 Oct; 30(5):693-700. PubMed ID: 21969132
[TBL] [Abstract][Full Text] [Related]
39. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
[TBL] [Abstract][Full Text] [Related]
40. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
